UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Concurrent cetuximab and radiotherapy after docetaxel–cisplatin induction chemotherapy in stage III NSCLC: Satellite—A phase II study from the Swedish Lung Cancer Study Group

Lung cancer (Amsterdam, Netherlands), 2011-02, Vol.71 (2), p.166-172

2011

Volltextzugriff (PDF)

Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy

European journal of cancer (1990), 2013-01, Vol.49 (1), p.115-120

2013

Volltextzugriff (PDF)

How to improve loco-regional control in stages IIIa―b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group

Lung cancer (Amsterdam, Netherlands), 2009-07, Vol.65 (1), p.62-67

2009

Volltextzugriff (PDF)

Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3290-3296

2009

Volltextzugriff (PDF)

Poe, "The House of Usher," and the American Gothic

1, 2009

Volltextzugriff (PDF)

Adapting Poe: Re-Imaginings in Popular Culture

1, 2012

Volltextzugriff (PDF)

How to improve loco-regional control in stages IIIa–b NSCLC?

Lung cancer (Amsterdam, Netherlands), 2009-07, Vol.65 (1), p.62-67

2009

Volltextzugriff (PDF)

Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8380-8388

2005

Volltextzugriff (PDF)

Gemcitabine versus gemcitabine/carboplatin in advanced non–small cell lung cancer: Preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

Seminars in oncology, 2002-06, Vol.29 (3), p.50-54

Sederholm, Christer

2002

Volltextzugriff (PDF)

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

Annals of oncology, 1997-06, Vol.8 (6), p.525-529

1997

Volltextzugriff (PDF)

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

Radiotherapy and oncology, 2008, Vol.88 (3), p.359-367

2008

Volltextzugriff (PDF)

A randomized phase 2 study of pemetrexed vs. pemetrexed+erlotinib in second-line treatment for locally advanced or metastatic, non-squamous NSCLC

Pneumologie (Stuttgart, Germany), 2012-03, Vol.66 (S 01)

2012

Volltextzugriff (PDF)

NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction

Acta oncologica, 2011, Vol.50 (4), p.518-527

2011

Volltextzugriff (PDF)

Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report

British journal of cancer, 1997-07, Vol.76 (2), p.175-179

1997

Volltextzugriff (PDF)

A randomized phase II study of pemetrexed versus pemetrexed plus erlotinib in second-line treatment for locally advanced or metastatic, nonsquamous NSCLC

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.7526-7526

2011

Volltextzugriff (PDF)

Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

Anticancer research, 2008-09, Vol.28 (5B), p.2851-2857

2008

Volltextzugriff (PDF)

A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer

Seminars in oncology, 1997-06, Vol.24 (3 Suppl 8), p.S8

1997

Volltextzugriff (PDF)

Initial safety results of an expanded access program (EAP) of erlotinib in non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.7190-7190

2006

Volltextzugriff (PDF)

A randomized phase III trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with small cell lung cancer, extensive disease (SCLC-ED): IRIS-Study

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.7523-7523

2007

Volltextzugriff (PDF)

D1-03: Treatment with irinotecan plus carboplatin prolongs survival without compromising quality of life in patients with small cell lung cancer, extensive disease (SCLC-ED). Results of a randomized phase III trial

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S390-S390

2007

Volltextzugriff (PDF)

Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 1999-11, Vol.26 (2), p.85-94

1999

Volltextzugriff (PDF)

IRIS – eine randomisierte Phase III Studie über Irinotecan plus Carboplatin versus Etoposid plus Carboplatin bei Patienten mit metastasiertem kleinzelligen Bronchialkarzinom

Pneumologie (Stuttgart, Germany), 2008, Vol.62 (S 2)

2008

Volltextzugriff (PDF)

A Poe within a Poe: Inception ’s Arabesque Play with “Ligeia”

Adapting Poe, 2012

2012

Volltextzugriff (PDF)

How to improve loco-regional control in stage IIIa-b NSCLC?: Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group

JOURNAL OF THORACIC ONCOLOGY, 2007, Vol.2 (8), p.S448

2007

Volltextzugriff (PDF)

NMR Determinations of Barriers to Internal Rotation in Halogen-Substituted Ethanes

The Journal of chemical physics, 1965-07, Vol.43 (2), p.602-623

1965

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Concurrent cetuximab and radiotherapy after docetaxel–cisplatin induction chemotherapy in stage III NSCLC: Satellite—A phase II study from the Swedish Lung Cancer Study Group

Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy

How to improve loco-regional control in stages IIIa―b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group

Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

Poe, "The House of Usher," and the American Gothic

Adapting Poe: Re-Imaginings in Popular Culture

How to improve loco-regional control in stages IIIa–b NSCLC?

Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Gemcitabine versus gemcitabine/carboplatin in advanced non–small cell lung cancer: Preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

A randomized phase 2 study of pemetrexed vs. pemetrexed+erlotinib in second-line treatment for locally advanced or metastatic, non-squamous NSCLC

NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction

Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report

A randomized phase II study of pemetrexed versus pemetrexed plus erlotinib in second-line treatment for locally advanced or metastatic, nonsquamous NSCLC

Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer

Initial safety results of an expanded access program (EAP) of erlotinib in non-small cell lung cancer (NSCLC)

A randomized phase III trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with small cell lung cancer, extensive disease (SCLC-ED): IRIS-Study

D1-03: Treatment with irinotecan plus carboplatin prolongs survival without compromising quality of life in patients with small cell lung cancer, extensive disease (SCLC-ED). Results of a randomized phase III trial

Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

IRIS – eine randomisierte Phase III Studie über Irinotecan plus Carboplatin versus Etoposid plus Carboplatin bei Patienten mit metastasiertem kleinzelligen Bronchialkarzinom

A Poe within a Poe: Inception ’s Arabesque Play with “Ligeia”

How to improve loco-regional control in stage IIIa-b NSCLC?: Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group

NMR Determinations of Barriers to Internal Rotation in Halogen-Substituted Ethanes

Suchergebnisse filtern